vimarsana.com

Latest Breaking News On - Bharat biotech covaxin - Page 5 : vimarsana.com

SEC approval for Bharat Biotech s COVID booster intranasal vaccine phase 3 trials

The SEC has asked the Hyderabad-based vaccine manufacturer to submit its revised protocol for trials

Andhra pradeshNew delhiExperts committeeSubject experts committeeDrug controller generalBharat biotechBharat biotech vaccineBharat biotech covid vaccineBharat biotech intranasal vaccineBharat biotech intranasal covid vaccineHarat biotech covid intranasal vaccineNtranasal vaccine bharat biotechNtranasal covid vaccine bharat biotechBharat biotech covaxinCovaxin covid vaccineHarat biotech covaxin covid vaccine

Biological E gets DCGI nod for Phase 3 clinical trials of Corbevax as booster dose

Biological E gets DCGI nod for Phase 3 clinical trials of Corbevax as booster dose - Biological E, Hyderabad-based pharmaceutical company on Tuesday received the emergency-use authorisation for manufacturing and marketing of Corbevax.

Andhra pradeshExpert committeeDrug controller generalBharat biotechBiologicale corbevaxPhase 3Clinical trialsDrug controller general of india dcgiBooster doseBharat biotech covaxinOvaxin booster shot

Bharat Biotech to begin Covaxin exports to additional countries from Dec

The Hyderabad-based vaccine maker stated that it has executed the long pending export orders during November.

Andhra pradeshSri lankaUnion territoriesSerum institute of indiaBharat biotechPune based serum instituteCovid 19 vaccineCovid 19 vaccine exportsOvaxin exportsBharat biotech covaxinHarat biotech covaxin exportsOvaxin exports from decemberOvaxin exports decemberOvaxin exports in decemberOvaxin exports to which countries

Bharat Biotech s partner seeks Covaxin approval in US for children below 18 years

The World Health Organisation on Wednesday granted approval for Emergency Use Listing Covaxin

New delhiRaches ellaSerum institute covishieldDrug administrationTechnical advisory groupWorld health organisationBharat biotechEmergency use authorisationEmergency use listingSerum instituteBharat biotechBharat biotech covaxinCovaxin who approvalWho approval covaxinOvaxin who eul approvalHo eul approval covaxin

How WHO nod for Bharat Biotech s Covaxin will benefit Indians

How WHO nod for Bharat Biotech's Covaxin will benefit Indians - Know here - WHO has approved Bharat Biotech’s Covaxin for emergency use listing yesterday, and this move can be beneficial for many Indians.

Narendra modiTechnical advisory groupBiopharmaceutical company ocugen incWorld health organisationBharat biotechEmergency use listingBiopharmaceutical company ocugenMinister narendra modiBharat biotechWorld health organisationCovaxin approvalEmergency use listingOvaxin emergency use approvalCovid 19 vaccineBharat biotech covaxinInternational travel

vimarsana © 2020. All Rights Reserved.